Navigation Links
Sequenom Announces Preliminary 2013 Operational Highlights And Objectives For 2014
Date:1/12/2014

er of payor contracts, including 2 national payors
  • Receiving reimbursement as an out-of-network laboratory from remaining large commercial payors
  • Medicaid volume was reduced to 14% of accessions in Q4 2013 from 25% in Q1 2013; eight state Medicaid payors are now reimbursing
  • Laboratory location in North Carolina fully operational and currently performing approximately one third of MaterniT21 PLUS tests
  • Mayo Clinic and Sequenom Laboratories partnered to provide access to the MaterniT21 PLUS LDT to the physicians and their patients in the Mayo Clinic network  
  • Massively parallel sequencing (MPS) patent issued in Europe, further strengthening Sequenom's prenatal diagnostic patent portfolio
  • "We overcame many significant challenges in 2013, including the coding changes that resulted in delays or reduced reimbursement by many payors, particularly state Medicaid programs. As we move into 2014, we continue to lead the industry in expanding the use of and reimbursement for noninvasive prenatal testing (NIPT), and continue to work with payors to gain coverage for our tests," said Harry F. Hixson, Jr., Ph.D., Chairman and CEO of Sequenom. "We have set high goals for 2014, and we expect to achieve these goals to continue to build value for our shareholders and maintain our leadership position in NIPT."

    Key Objectives for 2014

    The Company has established its primary financial and R&D objectives for 2014 to include:

    • Achieve quarterly break-even and positive cash flow in Q4 2014
    • Expand the NIPT menu with the development of a low cost test on an alternative platform by year-end, which we expect will facilitate international access and potential future entry into the low-risk market 

    On Thursday, January 16, at 2:00 p
    '/>"/>

    SOURCE Sequenom, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
    2. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
    3. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
    4. Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
    5. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
    6. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
    7. Sequenom Announces Participation At The Barclays Global Healthcare Conference
    8. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
    9. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
    10. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
    11. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... September 18, 2014 According ... (Surface & Intravascular Systems- Warming & Cooling), Application ... (Surgeon & Anesthesiologist, Nursing & Paramedical Staff) - ... MarketsandMarkets, this report studies the global Temperature Management Market ... The market is expected to reach $2.5 Billion ...
    (Date:9/18/2014)... SAN ANTONIO, Texas , Sept. 18, 2014  Casen ... vessels, skin and muscles to harden.  His case is one ... (GVM) in the world.  The only hospital in ... few in the world, offering treatment with the dual wave-length ... in San Antonio . Using a laser ...
    (Date:9/18/2014)... , Sept. 18, 2014 Research ... "China PTCA Balloon Market Investment Report, 2014-2016" ... as a indispensable medical device in percutaneous coronary intervention ... stent, but also as a device for pre-/post-stent dilatations. ... related to that of PCI. As national ...
    Breaking Medicine Technology:Temperature Management Market Worth $2.5 Billion by 2019 2Temperature Management Market Worth $2.5 Billion by 2019 3Temperature Management Market Worth $2.5 Billion by 2019 4Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3
    ... Medical Systems, a global developer of high-end ultrasound systems, ... number of clinical applications and ranked first or second ... KLAS  "Ultrasound 2011: Innovation on the Move" report. ... monitoring and reporting the performance of information technology and ...
    ... Suneva Medical, a privately-held aesthetic medical device ... aesthetics injectable business with approval from Health Canada ... dermal filler for nasolabial folds or smile line ... long-lasting treatment, Bellafill provides physicians the opportunity to ...
    Cached Medicine Technology:ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 2ZONARE Scores in Clinical Applications, Performance and Customer Support & Service in KLAS 2011 Ultrasound Report 3Suneva Medical Announces Canadian Approval of Bellafill™ 2
    (Date:9/18/2014)... Sunnyvale, California (PRWEB) September 18, 2014 ... Dr. Ellen Brown to the position of Chief Medical ... as Medical Director for several Pathways programs including Pathways ... for patients in San Mateo and Santa Clara Counties. ... for the medical component of Pathway’s patient care program. ...
    (Date:9/18/2014)... of the fight for superiority between mutated genes and ... leukaemia, say researchers from the University of Birmingham and ... Reports , investigated Acute Myeloid Leukaemia to understand why ... mature blood cells. , Stem cells in the bone ... The process resembles a production line with genes acting ...
    (Date:9/18/2014)... . In ecology, disease ... pathogen tooth and nail, but rather tolerate it to live (and ... is that the disease only progresses very slowly if at ... , Roland Regoes, a senior scientist at ETH Zurich,s Institute of ... about investigating whether there are infected people who are more tolerant ...
    (Date:9/18/2014)... (PRWEB) September 18, 2014 Clinical trial ... data on the Edema clinical trial scenario. This report ... trials on Edema. It includes an overview of the ... site of trial conduction across the globe. The databook ... their phase, trial status, prominence of the sponsors and ...
    (Date:9/18/2014)... September 18, 2014 This past August, Narconon ... from Roy at the kissing booth during the West Feliciana Animal ... Shelter. “I have loved animals my whole life and have ... those animals being strays who needed a home. Supporting an ... can’t take them all home!” , The CEO of Narconon Louisiana ...
    Breaking Medicine News(10 mins):Health News:Dr. Ellen Brown Promoted to Chief Medical Director at Pathways Home Health & Hospice 2Health News:The war on leukemia: How the battle for cell production could be decisive 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Narconon New Life Retreat Supports Local Animal Shelter At Recent Fundraiser 2
    ... set by CDC need to be lowered, experts say , ... levels well below those considered safe are still at risk ... , Currently, the maximum safe blood level of lead is ... the U.S. Centers for Disease Control and Prevention in 1991. ...
    ... ... of the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 ... healthcare communications company. The board provides guidance on innovative ways to leverage PerfectServe,s physician-contact ...
    ... PITTSBURGH, Sept. 17 DynaVox Mayer-Johnson, the world,s ... speech, language and learning disabilities, today announced the company received ... Microsoft Corp. This award recognizes DynaVox Mayer-Johnson for its ... products. , , "We are proud to ...
    ... LANSING, Mich., Sept. 17 Neogen Corporation (Nasdaq: NEOG ) announces the ... Neogen Corporation 1st Quarter Results Webcast, When: Thursday, September ... How: Live over the Internet -- Simply log on to ... Address above., Contact: Terry Maynard of Neogen Corporation, +1-800-234-5333., , ...
    ... Chief Operating Officer and Future CEO , , TORONTO, ... MDZ ), a leading provider of products and services ... West, President of MDS Nordion, has been appointed Chief Operating ... Chief Executive Officer of MDS Inc., intends to step down ...
    ... NEW YORK, Sept. 17 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) ... that develops novel therapeutic proteins that disrupt the ... signed a collaboration deal with Beckpharma Ltd. ("Beckpharma") ... treatments. , The two companies are joining forces ...
    Cached Medicine News:Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2Health News:DynaVox Mayer-Johnson Receives Microsoft Award 2Health News:MDS Announces CEO Transition Plan 2Health News:MDS Announces CEO Transition Plan 3Health News:MDS Announces CEO Transition Plan 4Health News:GENova Biotherapeutics secures new cancer drugs targets 2Health News:GENova Biotherapeutics secures new cancer drugs targets 3
    ... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
    ... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
    ... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
    ... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
    Medicine Products: